Comments on “dynamic <scp> <sup>18</sup> F‐FDG PET </scp> / <scp>CT</scp> can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comments on “dynamic ¹⁸ F‐FDG PET / CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer”

Published:2022-10-26 Issue:24 Volume:13 Page:3513-3514
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Wang Shan‐Ying¹²,Shiau Yu‐Chien¹,Hsu Chen‐Xiong²³^ORCID

Affiliation:

1. Department of Nuclear Medicine Far Eastern Memorial Hospital New Taipei City Taiwan

2. Department of Biomedical Imaging and Radiological Sciences National Yang Ming Chiao Tung University Taipei Taiwan

3. Division of Radiation Oncology, Department of Radiology Far Eastern Memorial Hospital New Taipei City Taiwan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14710

Reference7 articles.

1. Dynamic ¹⁸ F‐FDG PET / CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer

2. PET-Based Volumetric Biomarkers for Risk Stratification of Non-Small Cell Lung Cancer Patients

3. Noninvasive Evaluation of Microscopic Tumor Extensions Using Standardized Uptake Value and Metabolic Tumor Volume in Non-Small-Cell Lung Cancer

4. Imaging for Response Assessment in Cancer Clinical Trials

5. Integrating ¹⁸ F‐FDG PET / CT with lung dose‐volume for assessing lung inflammatory changes after arc‐based radiotherapy for esophageal cancer: A pilot study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer;Cancer Imaging;2024-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3